Invesco
KZR

Invesco’s Kezar Life Sciences KZR Stock Holding History

Invesco’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,948
Closed -$17.6K – 3932
2024
Q1 		$17.6K Sell
1,948
-123
-6% -$1.12K ﹤0.01% 3840
2023
Q4 		$19.6K Buy
2,071
+540
+35% +$4.75K ﹤0.01% 3804
2023
Q3 		$18.2K Buy
1,531
+191
+14% +$3.38K ﹤0.01% 3859
2023
Q2 		$32.8K Sell
1,340
-246
-16% -$6.4K ﹤0.01% 3841
2023
Q1 		$49.6K Sell
1,586
-87
-5% -$5.03K ﹤0.01% 3759
2022
Q4 		$118K Hold
1,673
– – ﹤0.01% 3799
2022
Q3 		$144K Buy
1,673
+59
+4% +$5.73K ﹤0.01% 3764
2022
Q2 		$133K Sell
1,614
-39,100
-96% -$3.45M ﹤0.01% 3830
2022
Q1 		$6.77M Sell
40,714
-23,882
-37% -$3.43M ﹤0.01% 2209
2021
Q4 		$10.8M Buy
64,596
+63,321
+4,966% +$7.15M ﹤0.01% 1965
2021
Q3 		$110K Buy
1,275
+137
+12% +$9.07K ﹤0.01% 3923
2021
Q2 		$62K Buy
1,138
+63
+6% +$3.58K ﹤0.01% 3936
2021
Q1 		$64K Buy
+1,075
New +$62.8K ﹤0.01% 3812

Other funds holding KZR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Invesco's KZR Position: Q2 2024 in Review

Invesco sold out of Kezar Life Sciences (KZR) in Q2 2024, closing a stake of 1,948 shares — an estimated $17.6K sold.

Invesco first reported a position in KZR in Q1 2021 and held it in 13 quarters. The position peaked at $10.8M in Q4 2021. 81 funds tracked by Wall St. Rank hold KZR as of Q2 2024.

  • Invesco reported no remaining Kezar Life Sciences position as of Q2 2024 after selling out during the quarter.
  • Invesco sold 1,948 Kezar Life Sciences shares in Q2 2024, an estimated $17.6K.
  • Invesco first reported a position in Kezar Life Sciences in Q1 2021 and held it in 13 quarters.
  • Invesco's Kezar Life Sciences position peaked at $10.8M in Q4 2021.
  • 81 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2024.

Based on Invesco's 13F filing for Q2 2024, filed 13 Aug 2024.